Wrapmanager Inc Veracyte, Inc. Transaction History

Wrapmanager Inc

$382 Million
Q3 2024

A detailed history of Wrapmanager Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Wrapmanager Inc holds 9,658 shares of VCYT stock, worth $394,915. This represents 0.09% of its overall portfolio holdings.

Number of Shares

9,658

Previous 17,910 46.07%

Holding current value

$394,915

Previous $388,000 15.46%

% of portfolio

0.09%

Previous 0.11%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$21.0 - $35.25 $173,292 - $290,883	-8,252 Reduced 46.07%	9,658 $328,000
Q2 2024 Aug 08, 2024	BUY	$18.86 - $23.55 $31,760 - $39,658	1,684 Added 10.38%	17,910 $388,000
Q1 2024 May 09, 2024	BUY	$21.0 - $29.1 $94,500 - $130,950	4,500 Added 38.38%	16,226 $359,000
Q4 2023 Feb 07, 2024	BUY	$19.72 - $28.68 $51,607 - $75,055	2,617 Added 28.73%	11,726 $322,000
Q3 2023 Nov 06, 2023	SELL	$22.33 - $29.92 $8,664 - $11,608	-388 Reduced 4.09%	9,109 $203,000
Q2 2023 Aug 08, 2023	SELL	$20.96 - $26.99 $7,901 - $10,175	-377 Reduced 3.82%	9,497 $241,000
Q1 2023 May 08, 2023	BUY	$20.58 - $27.89 $203,206 - $275,385	9,874 New	9,874 $220,000
Q3 2022 Nov 14, 2022	SELL	$16.58 - $27.9 $13,695 - $23,045	-826 Reduced 5.88%	13,210 $219,000
Q2 2022 Aug 05, 2022	BUY	$15.45 - $29.52 $20,409 - $38,995	1,321 Added 10.39%	14,036 $279,000
Q1 2022 May 10, 2022	BUY	$21.94 - $42.51 $86,465 - $167,531	3,941 Added 44.92%	12,715 $351,000
Q4 2021 Feb 07, 2022	SELL	$36.09 - $53.79 $18,081 - $26,948	-501 Reduced 5.4%	8,774 $361,000
Q3 2021 Nov 10, 2021	BUY	$35.62 - $52.97 $330,375 - $491,296	9,275 New	9,275 $431,000

Others Institutions Holding VCYT

# of Institutions

307

Shares Held

81.7M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.93B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wrapmanager Inc with notifications on news.

Account